Manual_digital

Cuidados

Continuos

240

Stopeck AT, Lipton A, Body JJ, et al. Denosumab compared with Zoledronic Acid for the

Treatment of bone metastases in patients with advanced breast cancer: a randomized, double-

blind study. J Clin Oncol 2010; 28: 5132-5139.

Fizazi K, Carducci MA, Smith MR et al. Denosumab versus zoledronic acid for the treatment

of bone metastases in men with castration-resistant prostate cancer: a randomized, double-

blind study. Lancet 2011; 377: 813-822.

Parker C, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Fossa SD. Alpha emitter radium-223

and survival in metastatic prostate cancer. N Engl J Med. 2013;369:213-23.

18.

19.

20.